Paul Daruwala is a biotech executive and consultant with more than 30 years of corporate leadership and drug development experience. He most recently served as President, CEO, and Director of Cellics Therapeutics, a preclinical-stage biotech developing cellular nanoparticles for autoimmune, inflammatory, and infectious diseases. From 2014 to 2022, he was Chief Operating and Chief Commercial Officer at Cidara Therapeutics, advancing a portfolio spanning discovery through NDA filing and helping raise over $250 million in funding. Earlier in his career, Paul held executive roles at Bristol Myers Squibb, Vertex Pharmaceuticals, and Merck & Co.
